Discovery of De Novo Oxime-containing Flavonoids as Potent Anticancer Agent against Human Nasopharyngeal Carcinomas:Structure-Activity Relationship and Mechanism Studies

CNU IR > Pharmacy and Science > 2011 Taiwanese-Russian Organic, Medicinal and Bio Chemistry Interactions & PST Medicinal Chemistry Symposium > Item 310902800/24216

Please use this identifier to cite or link to this item: https://ir.cnu.edu.tw/handle/310902800/24216

Title:	Discovery of De Novo Oxime-containing Flavonoids as Potent Anticancer Agent against Human Nasopharyngeal Carcinomas:Structure-Activity Relationship and Mechanism Studies
Authors:	Shin-Hun Juang (莊聲宏)
Date:	2011
Issue Date:	2011-06-23 14:57:09 (UTC+8)
Abstract:	Flavonoids and its derivatives are common components found in traditional Chinese medicine and food. Several studies indicated flavonoids could benefit in cancer prevention or therapy, but their structure-activity relationships (SAR) remain poorly defined. In order to further understand the SAR, a series of oxime-containing flavone derivatives were designed, synthesized and evaluated for their biological anti-cancer potential. The anti-proliferative ability of these compounds was measured by several human cancer cell lines from different origins including nasopiiaryngeal carcinoma, leukemia and lung carcinoma. Among over 30 different oxime-containing flavone derivatives, (Z)-6-[2-hydroxyimino-2-(4-methoxyphenyl ethoxy])- 2-phenyl-4H-l-benzopyran-4-one (WTC01) possessed most potent activity against human nasopharyngeal carcinoma cells growth with IC50 of 400 nM. As determined by flow cytometry, WTC01 treatment results in an accumulation of human nasopharyngeal carcinoma NPC-TW01 and HONE-1 cells in G2-M phase with time- and concentraton-dependent manner before cell death. Furthermore, Annexin-V/propidium iodide (PI) binding assay, Hoechst 33258/PI double staining, and PARP cleavage indicates that cell death proceed through an apoptotic pathway. Interestingly, WTC01 also causes mitochondrial transmembrane potential loss and activation of caspase-9 and caspase-3 without noticeable activation of the caspase-8. These results suggest that the WTC01-mediated apoptotic signaling pathway depends on the mitochondria and caspase-9/-3 cascades. Further studies showed that WTC01 inhibits tubulin assembly through binding to the colchicine-binding site of tubulin, this data suggests that tubulin may serve as the cellular target for WTC01. Notably, the in vivo study showed that WTC01 exhibits good pharmacokinetic properties and completely inhibits the growth of NPC-TW01 xenograft tumor at i.p. doeses of 25 and 50 mg/kg in nude mice. Taken together, these findings indicated that WTC01, a novel synthetic oxime-containing flavone, exhibits potent activity against cancer growth through the disruption of microtubule and has potential for management of nasopharyngeal malignancies.
Relation:	2011年台俄有機、藥物與生物化學交流暨藥物化學研討會，起迄日：2011/04/06~2011/04/05，地點：溪頭台大實驗林
Appears in Collections:	[Pharmacy and Science] 2011 Taiwanese-Russian Organic, Medicinal and Bio Chemistry Interactions & PST Medicinal Chemistry Symposium

Files in This Item:

File	Description	Size	Format
il-16.pdf		111Kb	Adobe PDF	469	View/Open

Loading...